ArticleScientific reports2024

Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study.

Jia Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.